TABLE 3.

Metabolic features of the subjects.

Variable	Mean ± SD	Me (Q1, Q3)	Min–Max	Norms
TC (mmol/L)	4.68 ± 1.04	4.57 (4.10, 5.50)	2.75–6.67	<5.2
LDL-C (mmol/L)	2.72 ± 0.96	2.40 (2.40, 3.45)	1.13–4.92	<3.0
HDL-C (mmol/L)	1.35 ± 0.30	1.25 (1.15, 1.58)	0.93–1.90	>1.2
TG (mmol/L)	1.19 ± 0.61	1.16 (0.75, 1.37)	0.29–2.53	0.2–1.7
GLU (mmol/L)	5.63 ± 2.34	5.11 (4.48, 5.60)	4.11–13.52	3.4–5.5
HbA1c (%)	5.35 ± 1.31	5.14 (4.94, 5.43)	3.56–9.60	4.3–5.9
INS (μU/mL)	15.20 ± 6.86	16.35 (7.30, 17.20)	6.10–29.20	2–15
HOMA-IR	3.82 ± 2.26	3.90 (1.62, 4.35)	1.11–10.03	<2.5
Quicki	0.32 ± 0.03	0.31 (0.31, 0.36)	0.28–0.38	>0.34
TyG	8.40 ± 0.68	8.46 (7.89, 8.72)	7.27–10.01	None
Asprosin (ng/mL)	14.38 ± 15.99	8.59 (4.18, 12.42)	2.37–47.26	None
LEPT (ng/mL)	26.53 ± 8.47	29.46 (22.75, 31.50)	9.22–36.60	7–13
ADIPO (μg/mL)	12.62 ± 5.38	11.16 (8.36, 17.83)	6.37–25.13	5–30
LEPT/ADIPO	2.38 ± 1.15	2.50 (1.45, 2.82)	0.79–5.12	None

SD, standard deviation; Me, median; Q1, lower quartile; Q3, upper quartile; TC, total cholesterol; LDL-C, low-density lipoproteins; HDL-C, high-density lipoproteins; TG, triglycerides; GLU, glucose; HbA1c, glycated haemoglobin; INS, insulin; HOMA-IR, homeostatic model assessment; Quicki, quantitative insulin sensitivity check index; TyG, triglyceride glucose (lnTG × GLU/2) index; LEPT, leptin; ADIPO, adiponectin.